Рынок реагентов и устройств для иммуноанализа в Азиатско-Тихоокеанском регионе, по продукту (реагенты и наборы, анализаторы), платформа (хемилюминесцентный иммуноанализ, флуоресцентный иммуноанализ, иммуноферментный анализ, радиоиммуноанализ и другие), метод (иммуноферментный анализ, экспресс-тесты, иммуноферментный спот, вестерн-блоттинг, иммуно-ПЦР и другие методы), тип образца (кровь, моча, слюна и другие), применение (инфекционные заболевания, онкология и эндокринология, заболевания костей и минералов, кардиология, гематология и скрининг крови, аутоиммунные заболевания, токсикология, неонатальный скрининг и другие приложения), конечный пользователь (больницы, клинические лаборатории, фармацевтические и биотехнологические компании, банки крови, исследовательские и академические лаборатории и Другие), страны (Китай, Япония, Индия, Австралия, Сингапур, Индонезия, Таиланд, Южная Корея, Малайзия, Филиппины, остальные страны Азиатско-Тихоокеанского региона). Отраслевые тенденции и прогноз до 2028 года.
Анализ рынка и аналитика: рынок реагентов и устройств для иммуноферментного анализа в Азиатско-Тихоокеанском регионе
Ожидается, что рынок реагентов и устройств для иммуноанализа будет расти в прогнозируемый период с 2021 по 2028 год. По данным Data Bridge Market Research, рынок будет расти со среднегодовым темпом роста 5,7% в прогнозируемый период с 2021 по 2028 год и, как ожидается, достигнет 9 737,46 млн долларов США к 2028 году. Ожидается, что рост распространенности заболеваний, для диагностики которых требуются технологически передовые продукты, чтобы избежать неправильной интерпретации, будет способствовать росту рынка реагентов и устройств для иммуноанализа в прогнозируемый период.
Иммуноферментный анализ — это тесты, которые проводятся для обнаружения определенных молекул в лабораториях. В основном это зависит от интегральной способности антитела прикрепляться к определенной структуре молекулы (антигена), присутствующей в образце. Антитела вырабатываются в организме в ответ на присутствие антигена в организме.
Появление пандемии COVID-19 привело к производству быстрых диагностических тестов (БДТ), которые используют методы иммуноанализа, как ожидается, послужат драйвером роста рынка реагентов и устройств для иммуноанализа. Отзыв продукции оказывает негативное влияние, поскольку производители вкладывают значительные суммы денег в замену или ремонт дефектных продуктов, что, в свою очередь, приводит к снижению доходов. Таким образом, это может стать серьезным сдерживающим фактором для рынка реагентов и устройств для иммуноанализа в прогнозируемый период. Ожидается, что увеличение исследований и разработок в области реагентов и устройств для иммуноанализа с целью предоставления улучшенных или новых продуктов на рынок создаст окно возможностей для роста рынка реагентов и устройств для иммуноанализа в прогнозируемый период. Ожидается, что наличие технологии жидкостной хроматографии-масс-спектрометрии в качестве альтернативного метода иммуноанализа для обнаружения биомолекул послужит вызовом для роста рынка реагентов и устройств для иммуноанализа.
Отчет о рынке реагентов и устройств для иммуноанализа содержит подробную информацию о доле рынка, новых разработках и анализе продуктового портфеля, влиянии внутренних и локальных игроков рынка, анализирует возможности с точки зрения новых источников дохода, изменений в рыночных правилах, одобрений продуктов, стратегических решений, запусков продуктов, географических расширений и технологических инноваций на рынке. Чтобы понять анализ и сценарий рынка реагентов и устройств для иммуноанализа, свяжитесь с Data Bridge Market Research для получения аналитического обзора, наша команда поможет вам создать решение по влиянию на доход для достижения желаемой цели.
Объем и размер рынка реагентов и устройств для иммуноферментного анализа
Рынок реагентов и устройств для иммуноанализа сегментирован по продукту, платформе, методике, типу образца, применению и конечному пользователю. Рост среди сегментов помогает вам анализировать нишевые карманы роста и стратегии выхода на рынок и определять основные области применения и разницу в ваших целевых рынках.
- На основе продукта рынок реагентов и устройств для иммуноанализа сегментируется на реагенты и наборы и анализаторы. В 2021 году сегмент реагентов и наборов доминирует из-за его более широкого использования в разработке лекарств, а также в выявлении заболеваний.
- На основе платформы рынок реагентов и устройств для иммуноферментного анализа сегментируется на хемилюминесцентный иммуноферментный анализ, флуоресцентный иммуноферментный анализ, иммуноферментный анализ, радиоиммуноферментный анализ и др. В 2021 году сегмент иммуноферментного анализа будет доминировать на рынке из-за своих преимуществ, таких как простота проведения теста, точный результат и многие другие.
- On the basis of technique, the immunoassay reagents and devices market is segmented into enzyme-linked immunosorbent assays, rapid tests, enzyme-linked immunospot, western blotting, immuno-PCR and other techniques. In 2021, enzyme-linked immunosorbent assays segment is dominating because it is highly sensitive, simple to perform, offer accurate result for any disease detection or in any drug development.
- On the basis of specimen type, the immunoassay reagents and devices market is segmented into saliva, urine, blood and others. In 2021, blood segment is dominating the market because antigen can be easily detected from the blood.
- On the basis of application, the immunoassay reagents and devices market is segmented into infectious diseases, oncology and endocrinology, bone & mineral disorders, cardiology, hematology & blood screening, autoimmune disorders, toxicology, neonatal screening and other applications. In 2021, oncology and endocrinology segment is dominating because of high incidence rate worldwide which can be detected easily with the use of immunoassays.
- On the basis of end user, the immunoassay reagents and devices market is segmented into hospitals, clinical laboratories, pharmaceutical and biotechnology companies, blood banks, research & academic laboratories and others. In 2021, pharmaceutical and biotechnology companies segment is dominating the market because of high usage of immunoassays for the drug development.
Asia-Pacific Immunoassay Reagents and Devices Market Country Level Analysis
Asia-Pacific immunoassay reagents and devices market is analyzed and market size information is provided by the country, product, platform, technique, specimen type, application and end user as referenced above.
The countries covered in the Asia-Pacific immunoassay reagents and devices market report are the China, Japan, India, Australia, Singapore, Indonesia, Thailand, South Korea, Malaysia, Philippines and rest of Asia-Pacific.
China is leading the growth of the Asia-Pacific immunoassay reagents and devices market for platform segment due to presence of the highest number of immunoassay reagents and devices providers.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Asia-Pacific brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Growing Strategic Activities by Major Market Players to enhance the Awareness for Immunoassay Reagents and Devices is boosting the Immunoassay Reagents and Devices Market
The immunoassay reagents and devices market also provides you with detailed immunoassay reagents and devices market analysis for every country growth in immunoassay reagents and devices market. Additionally, it provides the detailed information regarding the immunoassay reagents and devices market players’ strategy and their geographical presence. The data is available for historic period 2010 to 2019.
Competitive Landscape and Immunoassay Reagents and Devices Market Share Analysis
The immunoassay reagents and devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to Asia-Pacific immunoassay reagents and devices market.
The major companies dealing in the Asia-Pacific immunoassay reagents and devices market report are F. Hoffmann-La Roche Ltd, Siemens, Randox Laboratories Ltd., Abbott, Bio-Rad Laboratories, Inc., Merck KGaA, Beckman Coulter, Inc. (a subsidiary of Danaher), Sysmex Corporation, bioMérieux SA, Thermo Fisher Scientific, Inc., BD, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Ortho Clinical Diagnostics, QIAGEN, Quidel Corporation, BioCheck, Inc., Bio-Techne, PerkinElmer Inc., Agilent Technologies, Inc., Luminex Corporation, MESO SCALE DIAGNOSTICS, LLC among other domestic players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Many contract, agreement and launches are also initiated by the companies’ worldwide which are also accelerating the immunoassay reagents and devices market.
For instance,
- In July 2020, Bio-Rad Laboratories, Inc., a global leader of life science research and clinical diagnostic products, announced that the company is launching a blood-based immunoassay kit to identify antibodies to the coronavirus SARS-CoV-2, the virus associated with COVID-19. Preliminary performance of the assay has been established and the kit is now undergoing clinical evaluation in several hospitals to further confirm clinical performance. Initial data collected on more than 700 samples has demonstrated specificity above 99 percent.
Collaboration, product launch, business expansion, award and recognition, joint ventures and other strategies by the market players is enhancing the company footprints in the immunoassay reagents and devices market which also provides the benefit for organization’s profit growth.
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Интерактивная панель анализа данных
- Панель анализа компании для возможностей с высоким потенциалом роста
- Доступ аналитика-исследователя для настройки и запросов
- Анализ конкурентов с помощью интерактивной панели
- Последние новости, обновления и анализ тенденций
- Используйте возможности сравнительного анализа для комплексного отслеживания конкурентов
Содержание
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF ASIA PACIFIC IMMUNOASSAY REAGENTS AND DEVICES MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
5 INDUSTRY INSIGHTS
5.1 NEW PRODUCT LAUNCHES:
5.2 REGULATIONS FOR IMMUNOASSAY REAGENT AND DEVICE MARKET –
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 RISING INCIDENCE OF CHRONIC AND INFECTIOUS DISEASES
6.1.2 EMERGENCE OF COVID-19 PANDEMIC
6.1.3 WIDE APPLICATION OF IMMUNOASSAY
6.1.4 INCREASING HEALTHCARE EXPENDITURE
6.1.5 WIDE USE IN DRUG SCREENING TESTS
6.2 RESTRAINTS
6.2.1 HIGH COST OF IMMUNOASSAY KITS AND DEVICES
6.2.2 PRODUCT RECALL OF IMMUNOASSAY KITS AND DEVICES
6.3 OPPORTUNITIES
6.3.1 INCREASE IN RESEARCH & DEVELOPMENT ACTIVITIES
6.3.2 STRATEGIC INITATIVES BY THE COMPANIES
6.3.3 TECHNOLOGICAL UPGRADATION AND ADVANCEMENTS IN BIOTECHNOLOGY
6.4 CHALLENGES
6.4.1 AVAILABILITY OFALTERNATIVE TECHNOLOGIES
6.4.2 COMPLEXICITY IN PERFORMING IMMUNOASSAY
7 ASIA PACIFIC IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PRODUCT
7.1 OVERVIEW
7.2 REAGENTS & KITS
7.2.1 ELISA REAGENTS & KITS
7.2.1.1 THIRD-GENERATION ELISA
7.2.1.2 FIFTH-GENERATION ELISA
7.2.1.3 FOURTH-GENERATION ELISA
7.2.1.4 FIRST-GENERATION ELISA
7.2.1.5 SECOND-GENERATION ELISA
7.2.2 ELISPOT REAGENTS & KITS
7.2.3 RAPID TEST REAGENTS & KITS
7.2.4 WESTERN BLOT REAGENTS & KITS
7.2.5 OTHER REAGENTS & KITS
7.3 ANALYZERS
7.3.1 BY TYPE
7.3.1.1 OPEN-ENDED SYSTEMS
7.3.1.2 CLOSED-ENDED SYSTEMS
7.3.2 BY DEVICE TYPE
7.3.2.1 BENCH-TOP
7.3.2.2 FLOOR STANDING
8 ASIA PACIFIC IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PLATFORM
8.1 OVERVIEW
8.2 ENZYME IMMUNOASSAY
8.3 FLUORESCENCE IMMUNOASSAYS
8.4 CHEMILUMINESCENCE IMMUNOASSAYS
8.5 RADIOIMMUNOASSAYS
8.6 OTHERS
9 ASIA PACIFIC IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TECHNIQUE
9.1 OVERVIEW
9.2 ENZYME-LINKED IMMUNOSORBENT ASSAYS
9.3 ENZYME-LINKED IMMUNOSPOT
9.4 RAPID TESTS
9.5 WESTERN BLOTTING
9.6 IMMUNO-PCR
9.7 OTHER TECHNIQUES
10 ASIA PACIFIC IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY SPECIMEN TYPE
10.1 OVERVIEW
10.2 BLOOD
10.3 URINE
10.4 SALIVA
10.5 OTHERS
11 ASIA PACIFIC IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY APPLICATION
11.1 OVERVIEW
11.2 ONCOLOGY AND ENDOCRINOLOGY
11.3 HEMATOLOGY & BLOOD SCREENING
11.4 CARDIOLOGY
11.5 INFECTIOUS DISEASES
11.6 BONE & MINERAL DISORDERS
11.7 AUTOIMMUNE DISORDERS
11.8 TOXICOLOGY
11.9 NEONATAL SCREENING
11.1 OTHER APPLICATIONS
12 ASIA PACIFIC IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY END USER
12.1 OVERVIEW
12.2 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
12.3 CLINICAL LABORATORIES
12.4 HOSPITALS
12.5 RESEARCH & ACADEMIC LABORATORIES
12.6 BLOOD BANKS
12.7 OTHERS
13 ASIA PACIFIC IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY REGION
13.1 ASIA-PACIFIC
13.1.1 CHINA
13.1.2 JAPAN
13.1.3 INDIA
13.1.4 SOUTH KOREA
13.1.5 AUSTRALIA
13.1.6 MALAYSIA
13.1.7 SINGAPORE
13.1.8 THAILAND
13.1.9 INDONESIA
13.1.10 PHILIPPINES
13.1.11 REST OF ASIA-PACIFIC
14 ASIA PACIFIC IMMUNOASSAY REAGENTS AND DEVICES MARKET: COMPANY LANDSCAPE
14.1 COMPANY SHARE ANALYSIS: ASIA PACIFIC
15 COMPANY PROFILE
15.1 F. HOFFMANN-LA ROCHE LTD
15.1.1 COMPANY SNAPSHOT
15.1.2 REVENUE ANALYSIS
15.1.3 COMPANY SHARE ANALYSIS
15.1.4 PRODUCT PORTFOLIO
15.1.5 RECENT DEVELOPMENTS
15.2 ABBOTT
15.2.1 COMPANY SNAPSHOT
15.2.2 REVENUE ANALYSIS
15.2.3 COMPANY SHARE ANALYSIS
15.2.4 2.3 PRODUCT PORTFOLIO
15.2.5 RECENT DEVELOPMENTS
15.3 DIASORIN S.P.A
15.3.1 COMPANY SNAPSHOT
15.3.2 REVENUE ANALYSIS
15.3.3 COMPANY SHARE ANALYSIS
15.3.4 PRODUCT PORTFOLIO
15.3.5 RECENT DEVELOPMENTS
15.4 PERKINELMER INC.
15.4.1 COMPANY SNAPSHOT
15.4.2 REVENUE ANALYSIS
15.4.3 COMPANY SHARE ANALYSIS
15.4.4 PRODUCT PORTFOLIO
15.4.5 RECENT DEVELOPMENTS
15.5 BIOMÉRIEUX SA
15.5.1 COMPANY SNAPSHOT
15.5.2 REVENUE ANALYSIS
15.5.3 COMPANY SHARE ANALYSIS
15.5.4 PRODUCT PORTFOLIO
15.5.5 RECENT DEVELOPMENTS
15.6 AGILENT TECHNOLOGIES, INC.
15.6.1 COMPANY SNAPSHOT
15.6.2 REVENUE ANALYSIS
15.6.3 PRODUCT PORTFOLIO
15.6.4 RECENT DEVELOPMENTS
15.7 BD
15.7.1 COMPANY SNAPSHOT
15.7.2 REVENUE ANALYSIS
15.7.3 PRODUCT PORTFOLIO
15.7.4 RECENT DEVELOPMENTS
15.8 BECKMAN COULTER, INC (A SUBSIDIARY OF DANAHER)
15.8.1 COMPANY SNAPSHOT
15.8.2 REVENUE ANALYSIS
15.8.3 PRODUCT PORTFOLIO
15.8.4 RECENT DEVELOPMENTS
15.9 BIOCHECK, INC.
15.9.1 COMPANY SNAPSHOT
15.9.2 PRODUCT PORTFOLIO
15.9.3 RECENT DEVELOPMENT
15.1 BIO-TECHNE
15.10.1 COMPANY SNAPSHOT
15.10.2 REVENUE ANALYSIS
15.10.3 PRODUCT PORTFOLIO
15.10.4 RECENT DEVELOPMENTS
15.11 BIO-RAD LABORATORIES, INC.
15.11.1 COMPANY SNAPSHOT
15.11.2 REVENUE ANALYSIS
15.11.3 PRODUCT PORTFOLIO
15.11.4 RECENT DEVELOPMENTS
15.12 LUMINEX CORPORATION
15.12.1 COMPANY SNAPSHOT
15.12.2 REVENUE ANALYSIS
15.12.3 PRODUCT PORTFOLIO
15.12.4 RECENT DEVELOPMENTS
15.13 MERCK KGAA
15.13.1 COMPANY SNAPSHOT
15.13.2 REVENUE ANALYSIS
15.13.3 PRODUCT PORTFOLIO
15.13.4 RECENT DEVELOPMENTS
15.14 MESO SCALE DIAGNOSTICS, LLC
15.14.1 COMPANY SNAPSHOT
15.14.2 PRODUCT PORTFOLIO
15.14.3 RECENT DEVELOPMENTS
15.15 ORTHO CLINICAL DIAGNOSTICS
15.15.1 COMPANY SNAPSHOT
15.15.2 REVENUE ANALYSIS
15.15.3 PRODUCT PORTFOLIO
15.15.4 RECENT DEVELOPMENTS
15.16 QIAGEN
15.16.1 COMPANY SNAPSHOT
15.16.2 REVENUE ANALYSIS
15.16.3 PRODUCT PORTFOLIO
15.16.4 RECENT DEVELOPMENTS
15.17 QUIDEL CORPORATION
15.17.1 COMPANY SNAPSHOT
15.17.2 REVENUE ANALYSIS
15.17.3 PRODUCT PORTFOLIO
15.17.4 RECENT DEVELOPMENTS
15.18 RANDOX LABORATORIES LTD.
15.18.1 COMPANY SNAPSHOT
15.18.2 PRODUCT PORTFOLIO
15.18.3 RECENT DEVELOPMENTS
15.19 SIEMENS
15.19.1 COMPANY SNAPSHOT
15.19.2 REVENUE ANALYSIS
15.19.3 PRODUCT PORTFOLIO
15.19.4 RECENT DEVELOPMENTS
15.2 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
15.20.1 COMPANY SNAPSHOT
15.20.2 REVENUE ANALYSIS
15.20.3 PRODUCT PORTFOLIO
15.20.4 RECENT DEVELOPMENTS
15.21 SYSMEX CORPORATION
15.21.1 COMPANY SNAPSHOT
15.21.2 REVENUE ANALYSIS
15.21.3 PRODUCT PORTFOLIO
15.21.4 RECENT DEVELOPMENTS
15.22 THERMO FISHER SCIENTIFIC INC.
15.22.1 COMPANY SNAPSHOT
15.22.2 REVENUE ANALYSIS
15.22.3 PRODUCT PORTFOLIO
15.22.4 RECENT DEVELOPMENTS
16 QUESTIONNAIRE
17 RELATED REPORTS
Список таблиц
TABLE 1 COST OF ELISA KITS BY CELL SCIENCES, INC.
TABLE 2 ASIA PACIFIC IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 3 ASIA PACIFIC REAGENTS AND KITS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 4 ASIA PACIFIC REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 5 ASIA PACIFIC ELISA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 6 ASIA PACIFIC ANALYZERS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 7 ASIA PACIFIC ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 8 ASIA PACIFIC ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY DEVICE TYPE, 2019-2028 (USD MILLION)
TABLE 9 ASIA PACIFIC IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PLATFORM, 2019-2028 (USD MILLION)
TABLE 10 ASIA PACIFIC ENZYME IMMUNOASSAY IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 11 ASIA PACIFIC FLUORESCENCE IMMUNOASSAYS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 12 ASIA PACIFIC CHEMILUMINESCENCE IMMUNOASSAYS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 13 ASIA PACIFIC RADIOIMMUNOASSAYS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 14 ASIA PACIFIC OTHERS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 15 ASIA PACIFIC IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 16 ASIA PACIFIC ENZYME-LINKED IMMUNOSORBENT ASSAYS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 17 ASIA PACIFIC ENZYME-LINKED IMMUNOSPOT IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 18 ASIA PACIFIC RAPID TESTS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 19 ASIA PACIFIC WESTERN BLOTTING IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 20 ASIA PACIFIC IMMUNO-PCR IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 21 ASIA PACIFIC OTHER TECHNIQUES IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 22 ASIA PACIFIC IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY SPECIMEN TYPE, 2019-2028 (USD MILLION)
TABLE 23 ASIA PACIFIC BLOOD IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 24 ASIA PACIFIC URINE IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 25 ASIA PACIFIC SALIVA IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 26 ASIA PACIFIC OTHERS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 27 ASIA PACIFIC IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 28 ASIA PACIFIC ONCOLOGY AND ENDOCRINOLOGY IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 29 ASIA PACIFIC HEMATOLOGY & BLOOD SCREENING IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 30 ASIA PACIFIC CARDIOLOGY IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 31 ASIA PACIFIC INFECTIOUS DISEASES IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 32 ASIA PACIFIC BONE & MINERAL DISORDERS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 33 ASIA PACIFIC AUTOIMMUNE DISORDERS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 34 ASIA PACIFIC TOXICOLOGY IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 35 ASIA PACIFIC NEONATAL SCREENING IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 36 ASIA PACIFIC OTHER APPLICATIONS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 37 ASIA PACIFIC IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 38 ASIA PACIFIC PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 39 ASIA PACIFIC CLINICAL LABORATORIES IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 40 ASIA PACIFIC HOSPITALS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 41 ASIA PACIFIC RESEARCH & ACADEMIC LABORATORIES IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 42 ASIA PACIFIC BLOOD BANKS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 43 ASIA PACIFIC OTHERS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 44 ASIA-PACIFIC IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY COUNTRY, 2019-2028 (USD MILLION)
TABLE 45 ASIA-PACIFIC IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 46 ASIA-PACIFIC ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 47 ASIA-PACIFIC ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY DEVICE TYPE, 2019-2028 (USD MILLION)
TABLE 48 ASIA-PACIFIC REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 49 ASIA-PACIFIC ELISA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 50 ASIA-PACIFIC IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PLATFORM, 2019-2028 (USD MILLION)
TABLE 51 ASIA-PACIFIC IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 52 ASIA-PACIFIC IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY SPECIMEN TYPE, 2019-2028 (USD MILLION)
TABLE 53 ASIA-PACIFIC IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 54 ASIA-PACIFIC IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 55 CHINA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 56 CHINA ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 57 CHINA ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY DEVICE TYPE, 2019-2028 (USD MILLION)
TABLE 58 CHINA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 59 CHINA ELISA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 60 CHINA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PLATFORM, 2019-2028 (USD MILLION)
TABLE 61 CHINA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 62 CHINA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY SPECIMEN TYPE, 2019-2028 (USD MILLION)
TABLE 63 CHINA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 64 CHINA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 65 JAPAN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 66 JAPAN ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 67 JAPAN ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY DEVICE TYPE, 2019-2028 (USD MILLION)
TABLE 68 JAPAN REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 69 JAPAN ELISA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 70 JAPAN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PLATFORM, 2019-2028 (USD MILLION)
TABLE 71 JAPAN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 72 JAPAN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY SPECIMEN TYPE, 2019-2028 (USD MILLION)
TABLE 73 JAPAN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 74 JAPAN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 75 INDIA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 76 INDIA ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 77 INDIA ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY DEVICE TYPE, 2019-2028 (USD MILLION)
TABLE 78 INDIA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 79 INDIA ELISA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 80 INDIA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PLATFORM, 2019-2028 (USD MILLION)
TABLE 81 INDIA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 82 INDIA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY SPECIMEN TYPE, 2019-2028 (USD MILLION)
TABLE 83 INDIA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 84 INDIA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 85 SOUTH KOREA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 86 SOUTH KOREA ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 87 SOUTH KOREA ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY DEVICE TYPE, 2019-2028 (USD MILLION)
TABLE 88 SOUTH KOREA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 89 SOUTH KOREA ELISA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 90 SOUTH KOREA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PLATFORM, 2019-2028 (USD MILLION)
TABLE 91 SOUTH KOREA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 92 SOUTH KOREA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY SPECIMEN TYPE, 2019-2028 (USD MILLION)
TABLE 93 SOUTH KOREA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 94 SOUTH KOREA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 95 AUSTRALIA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 96 AUSTRALIA ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 97 AUSTRALIA ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY DEVICE TYPE, 2019-2028 (USD MILLION)
TABLE 98 AUSTRALIA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 99 AUSTRALIA ELISA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 100 AUSTRALIA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PLATFORM, 2019-2028 (USD MILLION)
TABLE 101 AUSTRALIA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 102 AUSTRALIA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY SPECIMEN TYPE, 2019-2028 (USD MILLION)
TABLE 103 AUSTRALIA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 104 AUSTRALIA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 105 MALAYSIA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 106 MALAYSIA ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 107 MALAYSIA ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY DEVICE TYPE, 2019-2028 (USD MILLION)
TABLE 108 MALAYSIA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 109 MALAYSIA ELISA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 110 MALAYSIA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PLATFORM, 2019-2028 (USD MILLION)
TABLE 111 MALAYSIA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 112 MALAYSIA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY SPECIMEN TYPE, 2019-2028 (USD MILLION)
TABLE 113 MALAYSIA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 114 MALAYSIA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 115 SINGAPORE IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 116 SINGAPORE ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 117 SINGAPORE ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY DEVICE TYPE, 2019-2028 (USD MILLION)
TABLE 118 SINGAPORE REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 119 SINGAPORE ELISA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 120 SINGAPORE IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PLATFORM, 2019-2028 (USD MILLION)
TABLE 121 SINGAPORE IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 122 SINGAPORE IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY SPECIMEN TYPE, 2019-2028 (USD MILLION)
TABLE 123 SINGAPORE IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 124 SINGAPORE IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 125 THAILAND IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 126 THAILAND ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 127 THAILAND ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY DEVICE TYPE, 2019-2028 (USD MILLION)
TABLE 128 THAILAND REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 129 THAILAND ELISA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 130 THAILAND IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PLATFORM, 2019-2028 (USD MILLION)
TABLE 131 THAILAND IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 132 THAILAND IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY SPECIMEN TYPE, 2019-2028 (USD MILLION)
TABLE 133 THAILAND IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 134 THAILAND IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 135 INDONESIA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 136 INDONESIA ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 137 INDONESIA ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY DEVICE TYPE, 2019-2028 (USD MILLION)
TABLE 138 INDONESIA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 139 INDONESIA ELISA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 140 INDONESIA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PLATFORM, 2019-2028 (USD MILLION)
TABLE 141 INDONESIA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 142 INDONESIA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY SPECIMEN TYPE, 2019-2028 (USD MILLION)
TABLE 143 INDONESIA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 144 INDONESIA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 145 PHILIPPINES IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 146 PHILIPPINES ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 147 PHILIPPINES ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY DEVICE TYPE, 2019-2028 (USD MILLION)
TABLE 148 PHILIPPINES REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 149 PHILIPPINES ELISA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 150 PHILIPPINES IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PLATFORM, 2019-2028 (USD MILLION)
TABLE 151 PHILIPPINES IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 152 PHILIPPINES IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY SPECIMEN TYPE, 2019-2028 (USD MILLION)
TABLE 153 PHILIPPINES IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 154 PHILIPPINES IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 155 REST OF ASIA-PACIFIC IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
Список рисунков
FIGURE 1 ASIA PACIFIC IMMUNOASSAY REAGENTS AND DEVICES MARKET: SEGMENTATION
FIGURE 2 ASIA PACIFIC IMMUNOASSAY REAGENTS AND DEVICES MARKET : DATA TRIANGULATION
FIGURE 3 ASIA PACIFIC IMMUNOASSAY REAGENTS AND DEVICES MARKET : DROC ANALYSIS
FIGURE 4 ASIA PACIFIC IMMUNOASSAY REAGENTS AND DEVICES MARKET : ASIA PACIFIC VS REGIONAL MARKET ANALYSIS
FIGURE 5 ASIA PACIFIC IMMUNOASSAY REAGENTS AND DEVICES MARKET : COMPANY RESEARCH ANALYSIS
FIGURE 6 ASIA PACIFIC IMMUNOASSAY REAGENTS AND DEVICES MARKET : INTERVIEW DEMOGRAPHICS
FIGURE 8 ASIA PACIFIC IMMUNOASSAY REAGENTS AND DEVICES MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 10 NORTH AMERICA IS EXPECTED TO DOMINATE THE ASIA PACIFIC IMMUNOASSAY REAGENTS AND DEVICES MARKET AND GROWING WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 11 INCREASING HEALTHCARE EXPENDITURE IS EXPECTED TO DRIVE THE GROWTH OF THE ASIA PACIFIC IMMUNOASSAY REAGENTS AND DEVICES MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 12 REAGENTS & KITS SEGMENT EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA PACIFIC IMMUNOASSAY REAGENTS AND DEVICES MARKET IN 2021 & 2028
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGE OF ASIA PACIFIC IMMUNOASSAY REAGENTS AND DEVICES MARKET
FIGURE 14 ASIA PACIFIC IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY PRODUCT, 2020
FIGURE 15 ASIA PACIFIC IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY PLATFORM, 2020
FIGURE 16 ASIA PACIFIC IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY TECHNIQUE, 2020
FIGURE 17 ASIA PACIFIC IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY SPECIMEN TYPE, 2020
FIGURE 18 ASIA PACIFIC IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY APPLICATION, 2020
FIGURE 19 ASIA PACIFIC IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY END USER, 2020
FIGURE 20 ASIA-PACIFIC IMMUNOASSAY REAGENTS AND DEVICES MARKET: SNAPSHOT (2020)
FIGURE 21 ASIA-PACIFIC IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY COUNTRY (2020)
FIGURE 22 ASIA-PACIFIC IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY COUNTRY (2021 & 2028)
FIGURE 23 ASIA-PACIFIC IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY COUNTRY (2020 & 2028)
FIGURE 24 ASIA-PACIFIC IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY PRODUCT (2021 & 2028)
FIGURE 25 ASIA PACIFIC IMMUNOASSAY REAGENTS AND DEVICES MARKET: COMPANY SHARE 2020 (%)
Методология исследования
Сбор данных и анализ базового года выполняются с использованием модулей сбора данных с большими размерами выборки. Этап включает получение рыночной информации или связанных данных из различных источников и стратегий. Он включает изучение и планирование всех данных, полученных из прошлого заранее. Он также охватывает изучение несоответствий информации, наблюдаемых в различных источниках информации. Рыночные данные анализируются и оцениваются с использованием статистических и последовательных моделей рынка. Кроме того, анализ доли рынка и анализ ключевых тенденций являются основными факторами успеха в отчете о рынке. Чтобы узнать больше, пожалуйста, запросите звонок аналитика или оставьте свой запрос.
Ключевой методологией исследования, используемой исследовательской группой DBMR, является триангуляция данных, которая включает в себя интеллектуальный анализ данных, анализ влияния переменных данных на рынок и первичную (отраслевую экспертную) проверку. Модели данных включают сетку позиционирования поставщиков, анализ временной линии рынка, обзор рынка и руководство, сетку позиционирования компании, патентный анализ, анализ цен, анализ доли рынка компании, стандарты измерения, глобальный и региональный анализ и анализ доли поставщика. Чтобы узнать больше о методологии исследования, отправьте запрос, чтобы поговорить с нашими отраслевыми экспертами.
Доступна настройка
Data Bridge Market Research является лидером в области передовых формативных исследований. Мы гордимся тем, что предоставляем нашим существующим и новым клиентам данные и анализ, которые соответствуют и подходят их целям. Отчет можно настроить, включив в него анализ ценовых тенденций целевых брендов, понимание рынка для дополнительных стран (запросите список стран), данные о результатах клинических испытаний, обзор литературы, обновленный анализ рынка и продуктовой базы. Анализ рынка целевых конкурентов можно проанализировать от анализа на основе технологий до стратегий портфеля рынка. Мы можем добавить столько конкурентов, о которых вам нужны данные в нужном вам формате и стиле данных. Наша команда аналитиков также может предоставить вам данные в сырых файлах Excel, сводных таблицах (книга фактов) или помочь вам в создании презентаций из наборов данных, доступных в отчете.
